Game On: Topokine Initiates Late-Stage Trial of XAF5 Ointment for Reining in Undereye Bags
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
GC Aesthetics has introduced Luna XT, the inaugural breast implant approved under the new European Medical Device Regulation, emphasizing enhanced safety amid increasing breast reconstruction surgeries.
The study, published in Lasers in Surgery and Medicine, looked at changes in scar melanin index after fractional ablative laser treatment in patients of various Fitzpatrick skin types.
Researchers from Florida Atlantic University have received a four-year, $1.2 million grant from the National Science Foundation to empower amputees to maximize their individual potential for controlling the full dexterity of artificial hands.
Advalight, which offers the ADVATx dermatology laser, announces that Beverly Hills, Calif.-based, board-certified plastic surgeon Daniel Barrett, MD, is now providing its non-ablative laser treatments.
Apyx Medical Corp.—developer of Helium Plasma Technology, which is marketed and sold as Renuvion® in the cosmetic surgery market—announces it has submitted a 510(k) premarket notification to the U.S. FDA.